Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities

Masahide Yazaki, Lawreen H. Connors, Ralph C. Eagle, Steven R. Leff, Martha Skinner, Merrill D. Benson

Research output: Contribution to journalArticle

8 Scopus citations


We report a 45-year-old woman with a new transthyretin (TTR) variant, substitution of leucine for tryptophan at residue 41, who has showed vitreous opacities without any other visceral organ involvement since age of 42. Congo red staining of vitrectomy specimens revealed that the vitreous fiuid contained amyloid fibrils, which were strongly positive for immunohistochemical staining using anti-human TTR antiserum. DNA analysis of the TTR gene showed a G to T transversion at the second nucleotide of codon 41, indicating a replacement of tryptophan (TGG) by leucine (TTG). These results indicate that the patient's vitreous amyloid is associated with this novel TTR mutation.

Original languageEnglish (US)
Pages (from-to)263-267
Number of pages5
Issue number4
StatePublished - Dec 2002


  • Amyloidosis
  • New transthyretin variant
  • Vitreous amyloid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities'. Together they form a unique fingerprint.

  • Cite this